Summary:
Gravitrex and Enlighten Mobility have formed a strategic partnership to accelerate the development and commercialization of gait training rehabilitation technologies aimed at improving access to walking recovery solutions for post-acute care patients.

Key Takeaways:

  • The partnership expands Gravitrex’s engineering, clinical, and commercialization capabilities to help bring its walking rehabilitation technology to market faster.
  • The collaboration addresses growing demand for scalable rehab solutions driven by an aging population and increasing rates of stroke and mobility-related conditions.
  • Gravitrex continues to build momentum through industry awards, research funding, and clinical validation efforts supporting its patented mobility rehabilitation platform.

Gravitrex Inc., a rehabilitation technology startup, announced a strategic partnership with Enlighten Mobility, known for its neuromotor innovation, to advance the development, commercialization, and clinical adoption of next-generation rehabilitation solutions. The partnership includes deployment of experienced personnel across engineering, clinical, and commercialization functions, which the company says will strengthen Gravitrex’s ability to scale operations and accelerate its path to market.

The collaboration comes at a time of increasing urgency in post-acute care, where a rapidly aging population and rising incidence of stroke and other mobility-impairing conditions are expected to significantly increase demand for rehabilitation services. Restoring walking ability is central to improving patient outcomes, yet clinicians are operating within constrained systems that often lack the resources to deliver high-quality mobility training at scale. In this context, accessible rehabilitation technology is emerging as a critical innovation category aimed at improving recovery outcomes while enabling more efficient, scalable care delivery across settings.

According to the company, this partnership with Enlighten Mobility builds on Gravitrex’s strong and growing momentum, including its American Physical Therapy Association (APTA) Academy of Leadership and Innovation (ALI) Shark Tank victory, international recognition through the Japan Prize at the global Pitch2Tokyo competition, and a $250,000 award from the Partnership for Economic Innovation’s WearTech Applied Research Center, to support R&D and clinical validation of Gravitrex’s lead product, designed for walking rehabilitation in post-acute care settings.

“By joining forces with Enlighten Mobility, we are significantly strengthening Gravitrex’s ability to execute across engineering, clinical, and commercialization functions,” said Kira Burns, CEO of Gravitrex. “This partnership expands our team with highly experienced talent, deepens our access to clinical and industry networks, and meaningfully accelerates our path to market. In a space as complex as neurorehabilitation, having partners who understand both the technical and clinical realities is critical—not only for scaling efficiently, but also for ensuring we deliver meaningful impact to patients.”

“The field of rehabilitation is evolving, creating a profound need for evidence-based rehabilitation technology across care settings,” said Marissa Koscielski, founder of Enlighten Mobility. “Gravitrex’s patient-first platform makes them strategically positioned to address this need in the neurorehabilitation sector. Their commitment to evidence-based, health-system-integrated solutions is rare and represents the gold standard for success. By merging our expertise with Gravitrex’s exceptional team and technology, we are accelerating a future where advanced recovery is accessible to everyone.”

This strategic partnership marks a significant milestone for Gravitrex as it advances its patented technology aimed at enabling safe, early walking rehabilitation for patients recovering from stroke, illness, or injury. The addition of Enlighten Mobility is expected to position Gravitrex to accelerate development, expand clinical partnerships, and broaden access to its technology.

About Gravitrex

Gravitrex, Inc. is a medical device company aiming to transform how healthcare professionals deliver walking rehabilitation for patients recovering from stroke, illness, or injury. Leveraging a novel patented technology, Gravitrex is developing a new device that partially supports a person’s weight during walking, to make rehabilitation safer, easier, and more accessible.

Headquartered in Phoenix, Arizona, Gravitrex is funded by the NIH’s National Institute on Aging, the WearTech Applied Research Center (funded by the Partnership for Economic Innovation), the University of Chicago Polsky Center, and other investors.

Learn more at https://www.gravitrexmobility.com.

Featured image: Dreamstime